TGF-β Signaling Pathway in Lung Adenocarcinoma Invasion

被引:50
作者
Toonkel, Rebecca L. [1 ]
Borczuk, Alain C. [2 ]
Powell, Charles A. [1 ]
机构
[1] Columbia Univ, Div Pulm & Crit Care Med, Med Ctr, New York, NY 10032 USA
[2] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10032 USA
关键词
Lung adenocarcinoma; Bronchioloalveolar carcinoma; Invasion; TGF-beta; TGF beta RII; RANTES; Lung cancer genomics; GROWTH-FACTOR-BETA; CANCER CELL-LINES; RECEPTOR-TYPE-II; TRANSFORMING GROWTH-FACTOR-BETA-1; SUPPRESSES METASTASIS; PERIPHERAL ADENOCARCINOMA; ENHANCES TUMORIGENESIS; PULMONARY METASTASIS; TUMOR PROGRESSION; POOR-PROGNOSIS;
D O I
10.1097/JTO.0b013e3181c8cc0c
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The histologic distinction between bronchioloalveolar carcinoma and other adenocarcinomas is tissue invasion. The clinical importance of lung adenocarcinoma invasion is supported by several recent Studies indicating that the risk of death in nonmucinous bronchioloalveolar carcinoma is significantly lower than that of pure invasive tumors and in tumors with greater than 0.5 ern of fibrosis or linear invasion. Using microarray gene expression profiling of human tumors, dysregulation of transforming growth factor-beta signaling was identified as an important mediator Of tumor invasion. Subsequent studies showed that the CC chemokine regulated on activation, normal T cell expressed, and presumably secreted was up-regulated in invasive tumors and was required for invasion in cells with repressed levels of the transforming growth factor-beta type II receptor. Taken together, these studies illustrate how information gained from global expression profiling of tumors can be used to identify key pathways and genes mediating turner growth, invasion, and metastasis.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 84 条
[1]   Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells [J].
Anumanthan, G ;
Halder, SK ;
Osada, H ;
Takahashi, T ;
Massion, PP ;
Carbone, DP ;
Datta, PK .
BRITISH JOURNAL OF CANCER, 2005, 93 (10) :1157-1167
[2]   Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-β type I receptor kinase inhibitor [J].
Bandyopadhyay, Abhik ;
Agyin, Joseph K. ;
Wang, Long ;
Tang, Yuping ;
Lei, Xiufen ;
Story, Beryl M. ;
Cornell, John E. ;
Pollock, Bradley H. ;
Mundy, Gregory R. ;
Sun, Lu-Zhe .
CANCER RESEARCH, 2006, 66 (13) :6714-6721
[3]   Increased TGFβ1 plasma level in patients with lung cancer:: potential mechanisms [J].
Barthelemy-Brichant, N ;
David, JL ;
Bosquée, L ;
Bury, T ;
Seidel, L ;
Albert, A ;
Bartsch, P ;
Baugnet-Mahieu, L ;
Deneufbourg, JM .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2002, 32 (03) :193-198
[4]   Gene-expression profiles predict survival of patients with lung adenocarcinoma [J].
Beer, DG ;
Kardia, SLR ;
Huang, CC ;
Giordano, TJ ;
Levin, AM ;
Misek, DE ;
Lin, L ;
Chen, GA ;
Gharib, TG ;
Thomas, DG ;
Lizyness, ML ;
Kuick, R ;
Hayasaka, S ;
Taylor, JMG ;
Iannettoni, MD ;
Orringer, MB ;
Hanash, S .
NATURE MEDICINE, 2002, 8 (08) :816-824
[5]   Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity [J].
Bhowmick, NA ;
Zent, R ;
Ghiassi, M ;
McDonnell, M ;
Moses, HL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :46707-46713
[6]   TGF-β and cancer [J].
Bierie, B ;
Moses, HL .
CYTOKINE & GROWTH FACTOR REVIEWS, 2006, 17 (1-2) :29-40
[7]   Putting tumours in context [J].
Bissell, MJ ;
Radisky, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :46-54
[8]   Transforming growth factor β receptor type II inactivation promotes the establishment and progression of colon cancer [J].
Biswas, S ;
Chytil, A ;
Washington, K ;
Romero-Gallo, J ;
Gorska, AE ;
Wirth, PS ;
Gautam, S ;
Moses, HL ;
Grady, WM .
CANCER RESEARCH, 2004, 64 (14) :4687-4692
[9]   Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression [J].
Biswas, Swati ;
Guix, Marta ;
Rinehart, Cammie ;
Dugger, Teresa C. ;
Chytil, Anna ;
Moses, Harold L. ;
Freeman, Michael L. ;
Arteaga, Carlos L. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1305-1313
[10]   Lung adenocarcinoma invasion in TGFbRII-deficient cells is mediated by CCL5/RANTES [J].
Borczuk, A. C. ;
Papanikolaou, N. ;
Toonkel, R. L. ;
Sole, M. ;
Gorenstein, L. A. ;
Ginsburg, M. E. ;
Sonett, J. R. ;
Friedman, R. A. ;
Powell, C. A. .
ONCOGENE, 2008, 27 (04) :557-564